Scholar Rock Holding (SRRK) Assets (2017 - 2026)
Scholar Rock Holding's quarterly Assets came in at $535.3 million in Q1 2026, up 31.33% year-on-year from $407.6 million in Q1 2025, and up 32.4% quarter-over-quarter from $404.3 million in Q4 2025.
Scholar Rock Holding has reported Assets for 10 years, with the latest figure at $535.3 million in Q1 2026.
- For the quarter ending Q1 2026, Assets rose 31.33% year-over-year to $535.3 million; the trailing twelve-month figure through Mar 2026 stood at $535.3 million (up 31.33% YoY), and the FY2025 full-year result was $404.3 million, down 14.88% from the prior year.
- Assets for Q1 2026 stood at $535.3 million, up from $404.3 million in the prior quarter.
- The five-year high for Assets was $535.3 million in Q1 2026, with the low at $179.1 million in Q3 2024.
- Average Assets over 5 years is $343.9 million, with a median of $340.0 million recorded in 2025.
- Year-over-year, Assets tumbled 35.77% in 2023 and jumped 129.84% in 2025.
- Tracing SRRK's Assets over 5 years: stood at $358.2 million in 2022, then dropped by 13.16% to $311.0 million in 2023, then surged by 52.69% to $474.9 million in 2024, then dropped by 14.88% to $404.3 million in 2025, then soared by 32.4% to $535.3 million in 2026.
- The last three Assets figures came in at $535.3 million (Q1 2026), $404.3 million (Q4 2025), and $411.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 14.93 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 37.37 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.73 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 78.88 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 33.89 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 26.48 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 23.64 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 40.87 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 5.13 Bn |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - | 535.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 535.25 Mn |
| Dec 31, 2025 | 404.27 Mn |
| Sep 30, 2025 | 411.72 Mn |
| Jun 30, 2025 | 340.05 Mn |
| Mar 31, 2025 | 407.55 Mn |
| Dec 31, 2024 | 474.92 Mn |
| Sep 30, 2024 | 179.13 Mn |
| Jun 30, 2024 | 226.87 Mn |
| Mar 31, 2024 | 267.29 Mn |
| Dec 31, 2023 | 311.04 Mn |
| Sep 30, 2023 | 250.69 Mn |
| Jun 30, 2023 | 284.90 Mn |
| Mar 31, 2023 | 314.72 Mn |
| Dec 31, 2022 | 358.17 Mn |
| Sep 30, 2022 | 390.30 Mn |
| Jun 30, 2022 | 424.13 Mn |
| Mar 31, 2022 | 265.98 Mn |
| Dec 31, 2021 | 304.45 Mn |
| Sep 30, 2021 | 298.39 Mn |
| Jun 30, 2021 | 332.05 Mn |
| Mar 31, 2021 | 360.59 Mn |
| Dec 31, 2020 | 388.31 Mn |
| Sep 30, 2020 | 163.42 Mn |
| Jun 30, 2020 | 156.36 Mn |
| Mar 31, 2020 | 175.70 Mn |
| Dec 31, 2019 | 196.38 Mn |
| Sep 30, 2019 | 188.54 Mn |
| Jun 30, 2019 | 196.91 Mn |
| Mar 31, 2019 | 170.98 Mn |
| Dec 31, 2018 | 181.34 Mn |
| Sep 30, 2018 | 109.02 Mn |
| Jun 30, 2018 | 118.98 Mn |
| Dec 31, 2017 | 61.64 Mn |